Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mereo BioPharma (MREO) Return on Sales (2023 - 2025)

Mereo BioPharma (MREO) has disclosed Return on Sales for 3 consecutive years, with 130.87% as the latest value for Q4 2025.

  • Quarterly Return on Sales changed N/A to 130.87% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 130.87% through Dec 2025, changed N/A year-over-year, with the annual reading at 83.76% for FY2025, N/A changed from the prior year.
  • Return on Sales for Q4 2025 was 130.87% at Mereo BioPharma, down from 129.92% in the prior quarter.
  • The five-year high for Return on Sales was 71.59% in Q1 2025, with the low at 130.87% in Q4 2025.
  • Average Return on Sales over 3 years is 31.81%, with a median of 19.7% recorded in 2025.
  • Peak annual rise in Return on Sales hit 7434bps in 2025, while the deepest fall reached -8354bps in 2025.
  • Over 3 years, Return on Sales stood at 10.17% in 2023, then tumbled by -356bps to 46.38% in 2024, then tumbled by -182bps to 130.87% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 130.87%, 129.92%, and 29.23% for Q4 2025, Q3 2025, and Q2 2025 respectively.